drugset / Trial / NCT04831541
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
To evaluate the potential usefulness of 68Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions, efficacy assessment and recurrence monitoring in various types of cancer.
Timeline
- Start
- 2020-10-10
- Primary completion
- 2024-12-30
- Completion
- 2024-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-PSMA-11 | Diagnostic / imaging agent | — | Intravenous |